Rich vs. Sparse Pharmacokinetic Sampling
Learn the differences between rich and sparse pharmacokinetic sampling, when each design is appropriate, how sampling intensity affects PK parameter estimation, and how sparse sampling supports population PK analysis.
Partial AUC and Regulatory Exposure Comparisons
Learn how partial AUC is calculated and interpreted, why regulators use partial exposure measures for selected drug products, and how pAUC supports bioequivalence and exposure comparisons.
PK Sampling Design and Informative Sampling Times
Learn how to design pharmacokinetic sampling schedules, choose informative sampling times, capture absorption, distribution, and elimination, and avoid common PK sampling design problems.
Noncompartmental Analysis: MRT and Terminal Half-Life
Learn how noncompartmental pharmacokinetic analysis uses AUC, AUMC, mean residence time, terminal elimination rate constant, and terminal half-life to summarize drug concentration-time data.
Noncompartmental Analysis: Core Concepts
Learn the core concepts of noncompartmental analysis, including AUC, Cmax, Tmax, terminal elimination, half-life, clearance, volume of distribution, and the assumptions behind NCA.
Noncompartmental Analysis: AUC and AUMC
Learn how noncompartmental analysis uses AUC and AUMC to quantify drug exposure and characterize pharmacokinetic behavior without requiring a compartmental model.
Log-Linear Analysis of the Terminal Phase
Learn how log-linear analysis identifies the terminal phase of a pharmacokinetic concentration-time profile, estimates the terminal elimination rate constant and half-life, and supports AUC extrapolation.
Interpreting Concentration-Time Profiles
Learn how to interpret pharmacokinetic concentration-time profiles, including absorption, distribution, elimination, Cmax, Tmax, AUC, terminal phases, dose proportionality, and common interpretation pitfalls.
Half-Life, Elimination Rate Constant, and Mean Residence Time
Learn how elimination rate constant, half-life, and mean residence time describe drug disposition, how they are related in simple PK models, and why route and model assumptions matter.
Cmax, Tmax, and Exposure Metrics in Clinical Pharmacology
Learn how Cmax, Tmax, AUC, and related exposure metrics summarize drug concentration-time profiles and describe the rate and extent of systemic exposure.